Pacer Advisors’s Humana HUM Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q1 | $1.65M | Sell |
9,499
-3,284
| -26% | -$673K | ﹤0.01% | 1000 |
|
|
2025
Q4 | $3.27M | Sell |
12,783
-2,010
| -14% | -$527K | 0.01% | 848 |
|
|
2025
Q3 | $3.85M | Buy |
14,793
+4,401
| +42% | +$1.16M | 0.01% | 792 |
|
|
2025
Q2 | $2.54M | Buy |
10,392
+4,255
| +69% | +$1.06M | 0.01% | 925 |
|
|
2025
Q1 | $1.62M | Sell |
6,137
-9,442
| -61% | -$2.55M | ﹤0.01% | 1032 |
|
|
2024
Q4 | $3.95M | Buy |
15,579
+5,750
| +59% | +$1.54M | 0.01% | 711 |
|
|
2024
Q3 | $3.11M | Buy |
9,829
+236
| +2% | +$84K | 0.01% | 794 |
|
|
2024
Q2 | $3.58M | Sell |
9,593
-312
| -3% | -$105K | 0.01% | 712 |
|
|
2024
Q1 | $3.43M | Buy |
9,905
+1,751
| +21% | +$664K | 0.01% | 686 |
|
|
2023
Q4 | $3.73M | Sell |
8,154
-735
| -8% | -$362K | 0.01% | 629 |
|
|
2023
Q3 | $4.32M | Buy |
8,889
+140
| +2% | +$65.8K | 0.02% | 487 |
|
|
2023
Q2 | $3.91M | Buy |
8,749
+991
| +13% | +$499K | 0.02% | 569 |
|
|
2023
Q1 | $3.77M | Buy |
7,758
+7,307
| +1,620% | +$3.61M | 0.02% | 603 |
|
|
2022
Q4 | $231K | Sell |
451
-3,350
| -88% | -$1.76M | ﹤0.01% | 2052 |
|
|
2022
Q3 | $1.84M | Sell |
3,801
-736
| -16% | -$358K | 0.01% | 440 |
|
|
2022
Q2 | $2.12M | Sell |
4,537
-6,439
| -59% | -$2.87M | 0.02% | 447 |
|
|
2022
Q1 | $4.78M | Buy |
10,976
+4,295
| +64% | +$1.8M | 0.04% | 429 |
|
|
2021
Q4 | $3.1M | Sell |
6,681
-1,704
| -20% | -$754K | 0.03% | 636 |
|
|
2021
Q3 | $3.26M | Sell |
8,385
-910
| -10% | -$386K | 0.04% | 558 |
|
|
2021
Q2 | $4.12M | Buy |
9,295
+2,147
| +30% | +$938K | 0.06% | 409 |
|
|
2021
Q1 | $3M | Sell |
7,148
-1,156
| -14% | -$461K | 0.05% | 406 |
|
|
2020
Q4 | $3.41M | Sell |
8,304
-2,459
| -23% | -$1.02M | 0.06% | 295 |
|
|
2020
Q3 | $4.46M | Sell |
10,763
-1,723
| -14% | -$693K | 0.09% | 163 |
|
|
2020
Q2 | $4.84M | Buy |
12,486
+12,292
| +6,336% | +$4.6M | 0.1% | 158 |
|
|
2020
Q1 | $72K | Hold |
194
| – | – | ﹤0.01% | 519 |
|
|
2019
Q4 | $71K | Sell |
194
-15,226
| -99% | -$4.83M | ﹤0.01% | 1160 |
|
|
2019
Q3 | $3.94M | Buy |
15,420
+1,633
| +12% | +$458K | 0.09% | 235 |
|
|
2019
Q2 | $3.66M | Buy |
13,787
+1,391
| +11% | +$353K | 0.09% | 237 |
|
|
2019
Q1 | $3.3M | Buy |
12,396
+12,208
| +6,494% | +$3.52M | 0.09% | 201 |
|
|
2018
Q4 | $54K | Sell |
188
-7,358
| -98% | -$2.33M | ﹤0.01% | 295 |
|
|
2018
Q3 | $2.55M | Buy |
7,546
+1,076
| +17% | +$350K | 0.1% | 234 |
|
|
2018
Q2 | $1.93M | Buy |
6,470
+1,116
| +21% | +$327K | 0.09% | 292 |
|
|
2018
Q1 | $1.44M | Buy |
5,354
+616
| +13% | +$167K | 0.08% | 315 |
|
|
2017
Q4 | $1.18M | Buy |
4,738
+1,784
| +60% | +$441K | 0.08% | 343 |
|
|
2017
Q3 | $720K | Buy |
2,954
+273
| +10% | +$66.9K | 0.06% | 451 |
|
|
2017
Q2 | $645K | Sell |
2,681
-129
| -5% | -$29.2K | 0.06% | 451 |
|
|
2017
Q1 | $579K | Buy |
2,810
+88
| +3% | +$18.2K | 0.07% | 410 |
|
|
2016
Q4 | $555K | Sell |
2,722
-16
| -0.6% | -$3.05K | 0.08% | 356 |
|
|
2016
Q3 | $484K | Sell |
2,738
-16
| -0.6% | -$2.78K | 0.07% | 377 |
|
|
2016
Q2 | $495K | Buy |
2,754
+269
| +11% | +$47.8K | 0.08% | 333 |
|
|
2016
Q1 | $455K | Buy |
2,485
+256
| +11% | +$44.4K | 0.1% | 201 |
|
|
2015
Q4 | $398K | Buy |
+2,229
| New | +$391K | 0.09% | 223 |
|
|
2013
Q4 | $1.01M | Buy |
+7,009
| New | +$687K | 0.24% | 117 |
|
Other funds holding HUM
VCM
VPM
SC
Pacer Advisors's HUM Position: Q1 2026 in Review
Pacer Advisors reduced its Humana (HUM) stake by 26% in Q1 2026, selling an estimated $673K and leaving 9,499 shares worth $1.65M. The position accounts for ﹤0.01% of the portfolio, ranked #1000.
Pacer Advisors first reported a position in HUM in Q4 2013 and has held it in 43 quarters since. The position peaked at $4.84M in Q2 2020. 779 funds tracked by Wall St. Rank hold HUM as of Q1 2026.
- Pacer Advisors held 9,499 shares of Humana worth $1.65M as of Q1 2026.
- Pacer Advisors sold 3,284 Humana shares in Q1 2026, an estimated $673K.
- Humana made up ﹤0.01% of Pacer Advisors's portfolio in Q1 2026, its #1000 holding.
- Pacer Advisors first reported a position in Humana in Q4 2013 and has held it in 43 quarters since.
- Pacer Advisors's Humana position peaked at $4.84M in Q2 2020.
- 779 funds tracked by Wall St. Rank held Humana as of Q1 2026.
Based on Pacer Advisors's 13F filing for Q1 2026, filed 6 May 2026.